Back
Supernus Pharmaceuticals, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
44
SUPN
Supernus Pharmaceuticals, Inc.
Last Price:
$49.50
Seasonality Move:
8.06%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiSupernus Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 19.5% based on the past 13 years of stock performance.
-
Supernus Pharmaceuticals, Inc. has risen higher in 8 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
-
Is Supernus Pharmaceuticals, Inc. Stock Undervalued?The current Supernus Pharmaceuticals, Inc. [SUPN] share price is $48.75. The Score for SUPN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 19.5% based on the past 13 years of stock performance.
Supernus Pharmaceuticals, Inc. Stock Rating
Sell
44
Supernus Pharmaceuticals, Inc. (SUPN)
is a Sell
Is Supernus Pharmaceuticals, Inc. overpriced?
-
Supernus Pharmaceuticals, Inc. has risen higher in 8 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
Supernus Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
57.65
52-Week Low:
29.16
Prediction Charts
Market Cap:
2.8B
Price in USD:
48.75
Volume:
495.5K
Beta:
1.08
Technical Analysis
SMA50:
48.26
SMA100:
46.07
SMA200:
39.15
52-Wk Change:
34.59%
Stock Predictions
-
Is Supernus Pharmaceuticals, Inc. stock public?Yes, Supernus Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Supernus Pharmaceuticals, Inc. stock quote today?The Supernus Pharmaceuticals, Inc. stock price is 48.75 USD today.
-
How to buy Supernus Pharmaceuticals, Inc. stock online?You can buy Supernus Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 46.39 | 45.59 | 46.57 | 45.53 |
| Dec-1 | 45.38 | 44.70 | 45.58 | 44.65 |
| Dec-2 | 44.70 | 44.12 | 44.90 | 44.09 |
| Dec-3 | 44.27 | 44.76 | 45.07 | 44.21 |
| Dec-4 | 44.76 | 45.10 | 45.10 | 44.28 |
| Dec-5 | 44.94 | 45.68 | 45.88 | 44.51 |
| Dec-8 | 46.32 | 47.16 | 47.26 | 45.75 |
| Dec-9 | 47.01 | 45.42 | 47.24 | 45.36 |
| Dec-10 | 45.62 | 46.16 | 46.90 | 45.43 |
| Dec-11 | 46.42 | 46.51 | 47.34 | 45.88 |
| Dec-12 | 46.96 | 47.16 | 47.57 | 46.36 |
| Dec-15 | 47.23 | 47.28 | 47.80 | 46.76 |
| Dec-16 | 47.28 | 48.32 | 48.84 | 47.20 |
| Dec-17 | 48.46 | 48.75 | 49.40 | 48.18 |
Supernus Pharmaceuticals, Inc. Earnings
Supernus Pharmaceuticals, Inc. Earnings Report: Per Share Supernus Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals, Inc. Forecast Revenue Growth
Supernus Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.43 per share.
* Supernus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.